GLPBio

DNA Damage/DNA Repair

Research Areas

Products Related to DNA Damage/DNA Repair(2107)

  • GC81674 structure
    GC81674MKI-3
    CAS: 3084702-28-0
    Purity: >98.00%

    MKI-3 is a selective microtubule-associated serine/threonine kinase-like ( MASTL ) inhibitor with an IC 50 of 5.72 nM and a K d of 1.89 nM.

  • GC81675 structure
    GC81675MKI-2 hydrochloride
    Purity: >99.50%

    MKI-2 hydrochloride is a selective MASTL inhibitor with an IC 50 of 37.44 nM.

  • GC81688 structure
    GC81688GSPT1 degrader-15
    CAS: 3060504-66-4
    Purity: >95.00%

    GSPT1 degrader-15 (Compound Lib-B-15O) is a potent and highly selective GSPT1 molecular gel degrader, with a DC 50 of 154 nM.

  • GC81720 structure
    GC81720DDO3602
    Purity: >98.00%

    DDO3602 is a PARP1 HSPTAC ( HSP90 -mediated proteolysis-targeting chimera) degrader, with a DC 50 of 490.3 nM against PARP1; its K d values for PARP1 and HSP90 are 66.5 nM and 1.64 nM, respectively.

  • GC81756 structure
    GC81756GHP-88310
    Purity: >98.00%

    GHP-88310 is an orally active broad-spectrum paramyxovirus and orthomyxovirus inhibitor that targets the L protein - RdRP complex, and exhibits activity against respiratory viruses and viruses of the genus Morbillivirus [1] [2] . GHP-88310 binds to the central cavity of the polymerase protein, blocks replicase and transcriptase activities, interferes with the viral life cycle and inhibits viral replication [1] [2] . GHP-88310 can be used in studies of paramyxovirus infections, including morbillivirus-like diseases, human parainfluenza virus type 3 infection and measles [1] [2] .

  • GC81757 structure
    GC817573-Ethoxy-5,6-dibromosalicylaldehyde
    CAS: 20041-64-9
    Purity: >99.50%

    3-Ethoxy-5,6-dibromosalicylaldehyde is an IRE1/ERN1 inhibitor, with an IC 50 of 0.12 μM, a K i of 71-88 nM, and a K d of 100 nM against the ribonuclease activity of hIRE1α, as well as an IC 50 of 4.8 μM against yeast Ire1.

  • GC81758 structure
    GC81758HDAC11-IN-5
    Purity: >98.00%

    HDAC11-IN-5 is a selective, potent and orally active HDAC11 inhibitor with an IC 50 of 0.021 μM.

  • GC81777 structure
    GC81777ABS-752 hydrochloride
    CAS: 2922884-90-8
    Purity: >98.50%

    ABS-752 hydrochloride is an orally active prodrug targeting CRBN-modulating molecular glue with selectivity in protein degradation.

  • GC81812 structure
  • GC81825 structure
    GC81825ASO-4625
    Purity: >98.00%

    ASO-4625 is a 20-nucleotide gapmer antisense oligonucleotide with a full phosphorothioate backbone and 2'-O-(2-methoxy) ethyl ribose modifications, which targets BCL2 mRNA and BCL2L1 mRNA.

  • GC81834 structure
    GC81834F3 peptide acetate
    Purity: >98.00%

    F3 peptide acetate is a nucleolin-binding tumor-homing peptide that mediates selective uptake and internalization by tumor cells.

  • GC81835 structure
    GC81835G4232
    Purity: >98.00%

    G4232 is an immune-silent BCL2 antisense oligonucleotide that binds to BCL2 mRNA to induce target degradation and inhibit Bcl-2 protein translation.

  • GC81851 structure
    GC81851Pancreatic Polypeptide, rat TFA
    Purity: >98.00%

    Pancreatic Polypeptide, rat TFA (Rat pancreatic polypeptide TFA) is a rat-derived Pancreatic Polypeptide.

  • GC81862 structure
    GC81862YJ1206 TFA
    Purity: >98.00%

    YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader.

  • GC81867 structure
    GC81867Ac-ETDK(myr)-AMC acetate
    Purity: >98.00%

    Ac-ETDK(myr)-AMC acetate is a DLAT-derived ε-N-myristoyllysine peptide substrate for fatty-acid deacylase HDAC11, used in fluorescence-based HDAC11 activity assays.

  • GC81871 structure
    GC81871CAP 6 m7G(LNA)(5')ppp(5')(2'OMeA)pG trisodium solution (100 mM ± 3 mM)
    Purity: >98.00%

    CAP 6 m7G(LNA)(5')ppp(5')(2'OMeA)pG trisodium solution (100 mM ± 3 mM) is a monomeric raw material that can be used for nucleic acid synthesis.

  • GC81873 structure
    GC81873Ciprofloxacin hydrochloride
    CAS: 86483-48-9
    Purity: >98.00%

    Ciprofloxacin hydrochloride (Bay-09867 hydrochloride) is an orally active, blood-brain barrier permeable fluoroquinolone antibacterial agent.

  • GC81879 structure
    GC81879NCP26 TFA
    Purity: >99.50%

    NCP26 TFA is an ATP-competitive ProRS inhibitor (with a K D of 271 nM in the absence of proline, and a K D of 0.35 nM in the presence of 100 μM proline).

  • GC81890 structure
    GC81890Temozolomide-¹⁵N
    Purity: >98.00%

    Temozolomide - 15 N (NSC 362856- 15 N) is the 15 N-labeled Temozolomide.

  • GC81892 structure
    GC81892Vevorisertib tetrahydrochloride
    Purity: >98.00%

    Vevorisertib tetrahydrochloride (ARQ 751 tetrahydrochloride) is an orally active allosteric AKT inhibitor that blocks AKT phosphorylation.

  • GC90483 structure
    GC90483Magainin 1 (trifluoroacetate salt)
    Purity: >95.00%

    Un peptide cationique antimicrobien

  • GC90549 structure
    GC905495-Aminoimidazole-4-carboxamide (hydrate)
    Purity: >95.00%

    Un précurseur synthétique

  • GC90657 structure
    GC90657COMC
    CAS: 106281-45-2
    Purity: >90.00%

    Un agent anticancéreux

  • GC90669 structure
    GC90669Negamycin (hydrochloride)
    Purity: >80.00%

    Un antibiotique